Healthcare Global Enterprises Limited (NSE:HCG) — Market Cap & Net Worth

$1.08 Billion USD  · Rs100.29 Billion INR  · Rank #8461

Market Cap & Net Worth: Healthcare Global Enterprises Limited (HCG)

Healthcare Global Enterprises Limited (NSE:HCG) has a market capitalization of $1.08 Billion (Rs100.29 Billion) as of August 4, 2026. Listed on the NSE stock exchange, this India-based company holds position #8461 globally and #431 in its home market, demonstrating a 0.78% increase in market value over the past year.

Market capitalization, also known as net worth in stock markets, is calculated by multiplying Healthcare Global Enterprises Limited's stock price Rs671.75 by its total outstanding shares 149302203 (149.30 Million). See HCG capital reinvestment ratio to understand how much of operating cash flow is reinvested back into capital assets.

Healthcare Global Enterprises Limited Market Cap History: 2016 to 2026

Healthcare Global Enterprises Limited's market capitalization history from 2016 to 2026. Data shows growth from $399.63 Million to $1.08 Billion (14.13% CAGR).

Index Memberships

Healthcare Global Enterprises Limited is a constituent of 2 market indices:

Index Total Market Cap Weight (%) Rank by Market Cap
NIFTY MICROCAP 250
NIFTYMICROCAP250
$152.67 Billion 0.71% #49 of 250
NIFTY TOTAL MARKET
NIFTYTOTALMKT
$3.30 Trillion 0.03% #359 of 750

Weight: Healthcare Global Enterprises Limited's market cap as a percentage of total index value. Rank: Position among all constituents by market cap.

Healthcare Global Enterprises Limited Market Cap to Earnings & Revenue Ratios Timeline

This chart shows how Healthcare Global Enterprises Limited's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.

Latest Price to Sales (P/S) Ratio

0.04x

Healthcare Global Enterprises Limited's market cap is 0.04 times its annual revenue

Industry average: 0.41x Lower than industry average

Latest Price to Earnings (P/E) Ratio

7.88x

Healthcare Global Enterprises Limited's market cap is 7.88 times its annual earnings

Industry average: 12.64x Lower than industry average

What These Ratios Tell Investors:

  • Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
  • Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
  • Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
  • Industry comparison provides context for whether the company is valued higher or lower than peers.
Year Market Cap (USD) Revenue (USD) Net Income (USD) P/S Ratio P/E Ratio
2017 $451.78 Million $7.00 Billion $221.73 Million 0.06x 2.04x
2018 $315.74 Million $8.31 Billion $205.23 Million 0.04x 1.54x
2019 $168.57 Million $9.79 Billion -$247.97 Million 0.02x N/A
2020 $262.78 Million $10.96 Billion -$1.07 Billion 0.02x N/A
2021 $385.58 Million $10.13 Billion -$1.93 Billion 0.04x N/A
2022 $464.13 Million $13.98 Billion $537.33 Million 0.03x 0.86x
2023 $590.15 Million $16.94 Billion $293.49 Million 0.03x 2.01x
2024 $789.80 Million $19.12 Billion $481.55 Million 0.04x 1.64x
2025 $1.07 Billion $22.23 Billion $444.10 Million 0.05x 2.41x
2026 $1.08 Billion $25.38 Billion $137.60 Million 0.04x 7.88x

Competitor Companies of HCG by Market Capitalization

Companies near Healthcare Global Enterprises Limited in the global market cap rankings as of August 4, 2026.

Key companies related to Healthcare Global Enterprises Limited by market ranking:

  • HCA Healthcare, Inc. (NYSE:HCA): Ranked #328 globally with a market cap of $80.16 Billion USD.
  • Fresenius SE & Co. KGaA (XETRA:FRE): Ranked #908 globally with a market cap of $29.19 Billion USD ( €24.97 Billion EUR).
  • FRESENIUS SE+CO. ADR 1/4 (F:FREA): Ranked #996 globally with a market cap of $26.87 Billion USD ( €22.98 Billion EUR).
  • IHH Healthcare Bhd (KLSE:5225): Ranked #1367 globally with a market cap of $18.41 Billion USD ( RM73.34 Billion MYR).
Market capitalization comparison (in billions USD)
Rank Company Symbol Market Cap Price
#328 HCA Healthcare, Inc. NYSE:HCA $80.16 Billion $406.61
#908 Fresenius SE & Co. KGaA XETRA:FRE $29.19 Billion €44.77
#996 FRESENIUS SE+CO. ADR 1/4 F:FREA $26.87 Billion €10.20
#1367 IHH Healthcare Bhd KLSE:5225 $18.41 Billion RM8.30

Healthcare Global Enterprises Limited Historical Marketcap From 2016 to 2026

Between 2016 and today, Healthcare Global Enterprises Limited's market cap moved from $399.63 Million to $ 1.08 Billion, with a yearly change of 14.13%.

Year Market Cap Change (%)
2026 Rs1.08 Billion +1.47%
2025 Rs1.07 Billion +35.34%
2024 Rs789.80 Million +33.83%
2023 Rs590.15 Million +27.15%
2022 Rs464.13 Million +20.37%
2021 Rs385.58 Million +46.73%
2020 Rs262.78 Million +55.89%
2019 Rs168.57 Million -46.61%
2018 Rs315.74 Million -30.11%
2017 Rs451.78 Million +13.05%
2016 Rs399.63 Million --

End of Day Market Cap According to Different Sources

On Aug 4th, 2026 the market cap of Healthcare Global Enterprises Limited was reported to be:

Source Market Cap
Yahoo Finance $1.08 Billion USD
MoneyControl $1.08 Billion USD
MarketWatch $1.08 Billion USD
marketcap.company $1.08 Billion USD
Reuters $1.08 Billion USD

Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.

About Healthcare Global Enterprises Limited

NSE:HCG India Medical Care Facilities
Market Cap
$1.08 Billion
Rs100.29 Billion INR
Market Cap Rank
#8461 Global
#431 in India
Share Price
Rs671.75
Change (1 day)
+0.08%
52-Week Range
Rs521.75 - Rs776.30
All Time High
Rs776.30
About

HealthCare Global Enterprises Limited provides medical and healthcare services in India and internationally. The company offers cancer diagnostics services, including genomics and molecular diagnostics, digital PET, preventive oncology, physical examination, laboratory tests, home health services, digital pathology, and CTC detection; treatment services, such as medical oncology and haemato-oncol… Read more